Skip to main content
padlock icon - secure page this page is secure

Publisher: Nature Publishing

Volume 17, Number 3, 2014

Folate intake and the risk of prostate cancer: a systematic review and meta-analysis
pp. 213-219(7)
Authors: Tio, M.; Andrici, J.; Cox, M. R.; Eslick, G. D.

Favourites:
ADD

Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review
pp. 220-226(7)
Authors: Sargos, P.; Ferretti, L.; Gross-Goupil, M.; Orre, M.; Cornelis, F.; Henriques de Figueiredo, B.; Houede, N.; Merino, C.; Roubaud, G.; Dallaudiere, B.

Favourites:
ADD

Comparison of outcomes after TURP versus photoselective vaporization of the prostate with respect to trainee involvement utilizing ACS NSQIP
pp. 227-232(6)
Authors: Olcese, S. P.; Derosa, R.; Kern, S. Q.; Lustik, M. B.; Sterbis, J. R.; McMann, L. P.

Favourites:
ADD

BMI is associated with larger index tumors and worse outcome after radical prostatectomy
pp. 233-237(5)
Authors: Hayashi, N.; Matsushima, M.; Kido, M.; Naruoka, T.; Furuta, A.; Furuta, N.; Takahashi, H.; Egawa, S.

Favourites:
ADD

Updated trends in imaging use in men diagnosed with prostate cancer
pp. 246-251(6)
Authors: Porten, S. P.; Smith, A.; Odisho, A. Y.; Litwin, M. S.; Saigal, C. S.; Carroll, P. R.; Cooperberg, M. R.

Favourites:
ADD

A pilot ‘window of opportunity’ neoadjuvant study of metformin in localised prostate cancer
pp. 252-258(7)
Authors: Joshua, A. M.; Zannella, V. E.; Downes, M. R.; Bowes, B.; Hersey, K.; Koritzinsky, M.; Schwab, M.; Hofmann, U.; Evans, A.; van der Kwast, T.

Favourites:
ADD

Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T
pp. 259-264(6)
Authors: Small, E. J.; Higano, C. S.; Kantoff, P. W.; Whitmore, J. B.; Frohlich, M. W.; Petrylak, D. P.

Favourites:
ADD

Lifestyle and health factors associated with progressing and remitting trajectories of untreated lower urinary tract symptoms among elderly men
pp. 265-272(8)
Authors: Marshall, L. M.; Holton, K. F.; Parsons, J. K.; Lapidus, J. A.; Ramsey, K.; Barrett-Connor, E.

Favourites:
ADD

The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act
pp. 273-279(7)
Authors: Mahal, B. A.; Aizer, A. A.; Ziehr, D. R.; Hyatt, A. S.; Lago-Hernandez, C.; Chen, Y. W.; Choueiri, T. K.; Hu, J. C.; Sweeney, C. J.; Beard, C. J.

Favourites:
ADD

Impact of NADiA ProsVue PSA slope on secondary treatment decisions after radical prostatectomy
pp. 280-285(6)
Authors: Moul, J. W.; Chen, D. Y.; Trabulsi, E. J.; Warlick, C. A.; Ruckle, H. C.; Porter, J. R.; Yoshida, J. S.; Adams, G. W.; Kella, N.; Matsunaga, G. S.

Favourites:
ADD

Population-based analysis of treatment modalities and survival for clinically localized small-cell carcinoma of the prostate
pp. 286-291(6)
Authors: Weiner, A. B.; Patel, S. G.; Richards, K. A.; Szmulewitz, R. Z.; Eggener, S. E.

Favourites:
ADD

Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate
pp. 292-299(8)
Authors: Kim, W.; Jones, J. O.; Diamond, M.; Haqq, C.; Molina, A.; Small, E. J.; Ryan, C. J.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more